Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-02 5:00 pm Purchase |
2025-03-31 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
328,746 10.300% |
33,724 (+11.43%) |
Filing History |
| 2025-02-14 5:01 pm Sale |
2024-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Armistice Capital, LLC | 100,400 4.990% |
-14,600 (-12.70%) |
Filing History |
| 2025-02-14 1:25 pm Purchase |
2024-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Ikarian Capital LLC | 140,000 6.800% |
140,000 (New Position) |
Filing History |
| 2025-01-03 5:50 pm Purchase |
2024-12-31 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
295,022 13.800% |
114,597 (+63.52%) |
Filing History |
| 2024-11-15 4:05 pm Purchase |
2024-11-13 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
180,425 8.900% |
180,425 (New Position) |
Filing History |
| 2024-11-14 3:22 pm Purchase |
2024-09-30 | 13G | Avenue Therapeutics, Inc. ATXI |
Armistice Capital, LLC | 115,000 7.210% |
115,000 (New Position) |
Filing History |
| 2024-05-02 4:02 pm Purchase |
2024-05-02 | 13G | Avenue Therapeutics, Inc. ATXI |
Davidow Robert L | 17,206 2.900% |
17,206 (New Position) |
Filing History |
| 2024-04-17 4:05 pm Purchase |
2024-04-16 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
47,521 8.000% |
33,533 (+239.74%) |
Filing History |
| 2024-01-02 3:45 pm Purchase |
2023-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
SABBY MANAGEMENT LLC | 8,814 11.000% |
5,294 (+150.40%) |
Filing History |
| 2023-12-13 4:03 pm Sale |
2023-12-11 | 13G | Avenue Therapeutics, Inc. ATXI |
Davidow Robert L | 17,464 9.890% |
-8,227 (-32.02%) |
Filing History |
| 2023-11-28 4:05 pm Purchase |
2023-10-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Davidow Robert L | 25,691 14.500% |
25,691 (New Position) |
Filing History |
| 2023-09-18 5:08 pm Purchase |
2023-09-08 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
13,987 12.100% |
13,987 (New Position) |
Filing History |
| 2023-02-14 11:22 am Sale |
2022-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
CVI Investments, Inc. | 3,347 4.900% |
-289 (-7.95%) |
Filing History |
| 2023-01-06 4:31 pm Purchase |
2022-12-31 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
7,710 11.300% |
4,296 (+125.86%) |
Filing History |
| 2023-01-04 08:25 am Purchase |
2022-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
SABBY MANAGEMENT LLC | 3,520 11.000% |
3,520 (New Position) |
Filing History |
| 2022-12-14 4:06 pm Sale |
2022-12-14 | 13G | Avenue Therapeutics, Inc. ATXI |
Nantahala Capital Management, LLC | 0 0.000% |
-1,292 (Position Closed) |
Filing History |
| 2022-10-19 07:26 am Sale |
2022-10-11 | 13D | Avenue Therapeutics, Inc. ATXI |
InvaGen Pharmaceuticals Inc. | 0 0.000% |
-9,476 (Position Closed) |
Filing History |
| 2022-10-17 12:01 pm Purchase |
2022-10-07 | 13G | Avenue Therapeutics, Inc. ATXI |
CVI Investments, Inc. | 3,636 6.600% |
3,636 (New Position) |
Filing History |
| 2022-10-17 06:01 am Purchase |
2022-10-11 | 13G | Avenue Therapeutics, Inc. ATXI |
Mitchell P. Kopin | 2,891 4.990% |
2,891 (New Position) |
Filing History |
| 2022-07-28 4:30 pm Purchase |
2022-07-25 | 13D | Avenue Therapeutics, Inc. ATXI |
InvaGen Pharmaceuticals Inc. | 9,476 46.950% |
533 (+5.96%) |
Filing History |